XBiotech XBIT
NASDAQ XBIT
$2.19 +0.01 (+0.46%)
At close: Sep 30, 2026 · 4:00 PM EDT

XBiotech (XBIT) EBITDA Margin (2020 - 2022)

Updated

XBiotech's EBITDA Margin came in at -794.91% for FY2022, down 672.95 percentage points from -121.96% in FY2021.

Analysis

XBiotech (XBIT) EBITDA Margin (2020 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put EBITDA Margin at -121.96% in FY2021 (-85.51 pp) and -36.45% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 35.95%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 49.01%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.02%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 33.11%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 46.01%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -124.26%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 39.10%
10 XBiotech 66.77 Mn 66.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -336.61%
Jun 30, 2022 -742.94%
Mar 31, 2022 -1,427.00%
Dec 31, 2021 -144.24%
Sep 30, 2021 -67.36%
Jun 30, 2021 -220.27%
Mar 31, 2021 -60.45%
Dec 31, 2020 -82.29%
Sep 30, 2020 -39.07%
Jun 30, 2020 -38.51%
Mar 31, 2020 -12.72%
API Access

XBiotech EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=XBIT&period=max&api_key=YOUR_API_KEY